AbbVie | ABBV - Trade Creditors

Stock Price
228.21
Daily Change
-1.27 -0.55%
Monthly
3.37%
Yearly
11.79%
Q1 Forecast
217.84

AbbVie reported $3.59B in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Abbott USD 4.12B 183M Sep/2025
ALKERMES USD 68M 31.21M Sep/2025
Amgen USD 20.89B 1.25B Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
Biogen USD 432M 18.9M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Coherus Biosciences USD 24.89M 12.73M Sep/2025
Eisai JPY 85.49B 4.76B Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Gilead Sciences USD 808M 226M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Infinity Pharmaceuticals USD 1.5M 433K Jun/2023
J&J USD 11.99B 2.37B Dec/2025
Medtronic USD 2.58B 26M Sep/2025
Merck USD 4.15B 102M Sep/2025
Neurocrine Biosciences USD 545.5M 425.6M Dec/2025
Novartis USD 4.56B 49M Sep/2025
Pacira USD 17.69M 12.44M Sep/2025
Perrigo USD 469.7M 19.3M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sanofi EUR 22.93B 927M Dec/2025
UCB EUR 3.29B 2.54B Jun/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
United Therapeutics USD 468M 36M Sep/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025
Zoetis USD 487M 77M Dec/2025